You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic Pancreas Ductal Adenocarcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Enfortumab vedotin
  • Kansas City, Kansas
    University of Kansas Cancer Center
Jun 23, 2023

Pancreas Cancer Trial in Seoul (Vactosertib)

Recruiting
  • Pancreas Cancer
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer Trial in Quebec city (Cholesterol metabolism disruption)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +3 more
  • Cholesterol metabolism disruption
  • Quebec city, Quebec, Canada
    CHU de Québec-Université Laval
Oct 17, 2022

Pancreas Cancer Trial (surufatinib + camrelizumab + nab-paclitaxel + S-1, nab-paclitaxel + gemcitabine)

Recruiting
  • Pancreatic Cancer
  • +3 more
  • surufatinib + camrelizumab + nab-paclitaxel + S-1
  • nab-paclitaxel + gemcitabine
  • Beijing, China
    Chinese PLA General Hospital
Sep 26, 2022

Pancreatic Tumors, Solid Tumors, Biliary Tract Cancer Trial (BI 907828)

Not yet recruiting
  • Pancreatic Neoplasms
  • +2 more
  • BI 907828
  • (no location specified)
Aug 22, 2022

Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Circulating Tumor Cell Trial in Montpellier (Detection of

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Detection of circulating tumor cells expressing Axl: CTC-AXL(+)
  • Montpellier, France
    CHU Montpellier
Jul 1, 2022

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Scottsdale (Paricalcitol (Zemplar))

Active, not recruiting
  • Pancreatic Cancer
  • +4 more
  • Paricalcitol (Zemplar)
  • Scottsdale, Arizona
    HonorHealth Research Institute
Feb 16, 2022

Pancreatic Cancer, Pancreas Cancer, Pancreatic Adenocarcinoma Resectable Trial in Scottsdale (Ascorbic Acid, Paclitaxel

Completed
  • Pancreatic Cancer
  • +4 more
  • Ascorbic Acid
  • +3 more
  • Scottsdale, Arizona
    HonorHealth Research Institute
Feb 10, 2022

Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Seattle (Autologous Mesothelin-specific

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Autologous Mesothelin-specific TCR-T Cells
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 31, 2023

Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (BXCL701, Pembrolizumab)

Not yet recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Jan 23, 2023

Most Total Pancreatectomies for Ductal Adenocarcinoma Can Be

Recruiting
  • Ductal Adenocarcinoma of the Pancreas
  • Whipple over the splenic artery
  • Total pancreatectomy
  • Taipei, Taiwan
    National Taiwan University Hospital
Nov 1, 2023

Pancreatic Ductal Adenocarcinoma Trial in Miami (Trametinib, Ruxolitinib, Retifanlimab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Miami, Florida
    University of Miami
Jun 27, 2022

Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • +12 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 30, 2022

Predict Lymphovascular Invasion in Pancreatic Ductal

Recruiting
  • Predictive Cancer Model
  • Pancreas Cancer
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Aug 10, 2023

    Pancreatic Ductal Adenocarcinoma Trial in Durham (HA Chemotherapy)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • HA Chemotherapy
    • Durham, North Carolina
      Duke University Health System
    Nov 22, 2022

    Metastatic Pancreatic Adenocarcinoma Trial in France (Gemcitabine, Paclitaxel)

    Completed
    • Metastatic Pancreatic Adenocarcinoma
    • Bayeux, France
    • +25 more
    May 17, 2022

    Pancreas Adenocarcinoma Trial in Suwon (Pancreatic ductal adenocarcinoma organoids and cancer-associated fibroblasts

    Recruiting
    • Pancreas Adenocarcinoma
    • Pancreatic ductal adenocarcinoma organoids and cancer-associated fibroblasts establishment group
    • Suwon, Gyeong Gi Do, Korea, Republic of
      Ajou University Hospital
    Oct 7, 2022

    PDAC - Pancreatic Ductal Adenocarcinoma Trial (Combination of sitagliptin+ gemcitabine + nab-paclitaxel)

    Not yet recruiting
    • PDAC - Pancreatic Ductal Adenocarcinoma
    • Combination of sitagliptin+ gemcitabine + nab-paclitaxel
    • (no location specified)
    Jul 9, 2023

    Metastatic Pancreatic Adenocarcinoma Trial in Ann Arbor (Devimistat, Modified FOLFIRINOX)

    Not yet recruiting
    • Metastatic Pancreatic Adenocarcinoma
    • Ann Arbor, Michigan
      Rogel Cancer Center
    Jun 26, 2023

    Metastatic Pancreatic Cancer Trial in Washington (Gemcitabine, Nab paclitaxel, Proglumide Dose level 1)

    Not yet recruiting
    • Metastatic Pancreatic Cancer
    • Washington, District of Columbia
      Lombardi Comprehensive Cancer Center, Georgetown University
    Apr 11, 2023

    Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

    Not yet recruiting
    • Pancreatic Acinar Cell Carcinoma
    • +6 more
    • Nab paclitaxel
    • +5 more
    • (no location specified)
    Oct 30, 2023

    Metastatic Adenocarcinoma of the Pancreas Trial in Soeul (Minnelide)

    Recruiting
    • Metastatic Adenocarcinoma of the Pancreas
    • Minnelide
    • Soeul, Korea, Republic of
      Samsung Medical Center
    Dec 8, 2022

    KRAS Activating Mutation, Metastatic Cancer, Pancreas Cancer Trial in Saint Louis (avutometinib (VS-6766) and defactinib in

    Recruiting
    • KRAS Activating Mutation
    • +4 more
    • avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 3, 2023

    Cell-Free DNA CHIP for Diagnosing Cancer

    Recruiting
    • Cancer of Pancreas
    • Non-Human Subject Research study.
    • Orlando, Florida
      University of Central Florida
    Nov 20, 2023

    Pancreatic Ductal Adenocarcinoma Trial in Houston (Pembrolizumab, Folfirinox)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Houston, Texas
    • +1 more
    Dec 15, 2022